Hepatorenal Syndrome

Hepatorenal syndrome (HRS) is a form of acute kidney injury that occurs in the setting of advanced liver disease — cirrhosis being the classic setup — and USMLE Step 1 tests it because the pathophysiology is counterintuitive: the problem starts with too much vasodilation (in the splanchnic circulation), not too little. A common misconception is that hepatic toxins are directly poisoning the kidney tissue, but the kidneys are histologically normal in HRS — the injury is purely functional. That splanchnic vasodilation drops effective arterial blood volume, which triggers compensatory renal vasoconstriction via RAAS and sympathetic activation, starving the kidneys of perfusion.

The exam hits HRS from three angles: mechanism (tracing the cascade from splanchnic vasodilation to renal shutdown), diagnosis (knowing it's a diagnosis of exclusion with specific steps you must complete first), and management (distinguishing bridge therapy from definitive cure). Vignettes often describe a cirrhotic patient with rising creatinine and oliguria — your job is to work through the exclusion criteria systematically, not just slap on the HRS label because the patient has ascites.

The biggest traps: students either think hepatic toxins are directly poisoning the kidneys (they're not — the kidneys are histologically normal in HRS), or they confuse terlipressin plus albumin as the endpoint of treatment when it's actually a bridge to transplant. USMLE Step 1 frequently tests whether you know that liver transplantation is the only definitive fix — because when you restore normal hepatic function, the hemodynamic derangement resolves and the kidneys recover on their own.